Markets & Finance

A historic heat dome pushed America's largest power grid to within 3,000 MW of its all-time record, forcing federal emergency orders that let regulators compel data centers onto backup generators and waive air-emission limits at peaking plants to prevent blackouts. The crisis exposed a structural fault: Goldman Sachs projects U.S. data-center electricity demand will more than double to 66 GW by 2027, and PJM's capacity-market costs have already risen $23 billion since 2025 from AI load growth alone—costs passed directly to residential ratepayers now paying 39% more for summer cooling than in 2020. Critically, NERC's May 2026 reliability assessment never flagged PJM as elevated risk, raising serious questions about whether planning tools can keep pace with AI-driven load growth before the next heat wave arrives.

The $TRUMP memecoin transferred roughly $3.8 to $4.5 billion in losses to approximately one million retail wallets while Trump-affiliated entities collected over $324 million in trading fees and disclosed $1.4 billion in crypto earnings — with 80 percent of token supply reserved for insiders at zero cost basis from day one. The SEC explicitly told buyers they had no legal protections, the CFTC brought only two digital-currency enforcement actions in two years, and the DOJ Public Integrity Section was cut from 30 prosecutors to five. Bloomberg's analysis found roughly 76 percent of token value among the top dinner-contest holders was foreign-owned, raising Foreign Emoluments Clause questions that no federal agency has publicly acted on.

A unanimous 9-0 FDA advisory committee vote drove Moderna shares roughly 70% higher in a month, yet Wall Street's median price target sits at $45 against a recent print near $80, reflecting a sharp divide between regulatory optimism and commercial reality. The clinical data are genuinely strong — 26.6% relative vaccine efficacy over standard-dose flu shots in a 40,000-person trial — but peak sales estimates cluster around $1 billion, the 65+ approval is accelerated and contingent on a Phase 4 commitment, and entrenched competitors control the formulary relationships that determine actual market share. With $7.5 billion in cash burning at roughly $1.3 billion per quarter and a 2028 breakeven target requiring both a clean August PDUFA and a broad ACIP recommendation, the stock move has priced the regulatory win but not yet the harder work of capturing it.

Rep. Dan Meuser and Rep. Gil Cisneros disclosed SpaceX stock purchases within six days of the company's $75 billion IPO, while sitting on the exact committees that oversee SpaceX's regulators and its largest federal customers. No law was broken, but the STOCK Act's enforcement mechanism tops out at a $200 late fee against a company holding $20.7 billion in promised government contracts. Three reform bills in the 119th Congress would ban individual stock trading outright, but none has passed.